bf/NYSE:TAK_icon.jpeg

NYSE:TAK

Takeda Pharmaceutical Company Limited

  • Stock

USD

Last Close

14.59

01/03 21:00

Market Cap

45.81B

Beta: 0.68

Volume Today

1.07M

Avg: 2.34M

PE Ratio

18.10

PFCF: −50.39

Dividend Yield

0.01%

Payout:161.87%

  • industry

    Drug Manufacturers / Specialty & Generic
  • exchange

    New York Stock Exchange
  • website

    www.takeda.com
  • ipo date

    Apr 26, 2000
  • full time employees

    47,347
  • currency

    USD

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of ga...Show More

founders

  • Bruno Villetelle
  • Chobei Takeda I

investors

PartnersFunding RoundInvestor NameLead Investor
Grant - TakedaBill & Melinda Gates FoundationNo

investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$32MVenture Round - Crescendo Biologics24-07-2023Crescendo Biologics
Grant - Red Sox FoundationYes03-04-2023Red Sox Foundation
Grant - Common ThreadsYes03-04-2023Common Threads
Grant - Mamas KitchenYes03-04-2023Mamas Kitchen
Grant - Project ScientistYes03-04-2023Project Scientist
Grant - Urban Farming Institute of BostonYes03-04-2023Urban Farming Institute of Boston
Grant - San Diego River Park FoundationYes03-04-2023San Diego River Park Foundation
Grant - AcumenYes03-04-2023Acumen
Grant - Out TeachYes03-04-2023Out Teach
Grant - Georgia OrganicsYes03-04-2023Georgia Organics

acquisitions

PriceAcquiree NameAnnounced DateTransaction Name
Nimbus Lakshmi13-12-2022Nimbus Lakshmi acquired by Takeda
Adaptate Biotherapeutics10-01-2022Adaptate Biotherapeutics acquired by Takeda
Maverick Therapeutics09-03-2021Maverick Therapeutics acquired by Takeda
$330MPvP Biologics26-02-2020PvP Biologics acquired by Takeda
£62BShire25-04-2018Shire acquired by Takeda
€520MTiGenix05-01-2018TiGenix acquired by Takeda
$5.2BARIAD Pharmaceuticals09-01-2017ARIAD Pharmaceuticals acquired by Takeda
Inviragen07-05-2013Inviragen acquired by Takeda
Envoy Therapeutics06-11-2012Envoy Therapeutics acquired by Takeda
$60MLigoCyte Pharmaceuticals05-10-2012LigoCyte Pharmaceuticals acquired by Takeda

num employees

  • 10001+

funding rounds

Money RaisedAnnounced DateLead InvestorsTransaction NameNumber of Investors
$19.8M01-09-2016Grant - Takeda
$38M08-05-2016Grant - Takeda1

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.